What Sitajub is

Sitajub contains the active substance Sitagliptin. which is a member of a class of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus.
This medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body.
Your doctor has prescribed this medicine to help lower your blood sugar, which is too high because of your type 2 diabetes. This medicine can be used alone or in combination with certain other medicines (insulin, metformin, sulphonylureas, or glitazones) that lower blood sugar, which you may already be taking for your diabetes, together with a food and exercise plan.
What is type 2 diabetes?
Type 2 diabetes is a condition in which your body does not make enough insulin, and the insulin that your body produces does not work as well as it should. Your body can also make too much sugar.
When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems like heart disease, kidney disease, blindness, and amputation.

Do not take Sitajub
 If you are allergic to Sitagliptin or any of the other ingredients of this medicine (listed
in section 6).
Warnings and precautions
Cases of inflammation of the pancreas (pancreatitis) have been reported in patients receiving
Sitajub (see section 4).
If you encounter blistering of the skin, it may be a sign of a condition called bullous
pemphigoid.
Your doctor may ask you to stop Sitajub.
Tell your doctor if you have or have had:
- a disease of the pancreas (such as pancreatitis)
- gallstones, alcohol dependence or very high levels of triglycerides (a form of fat) in
your blood.
- These medical conditions can increase your chance of getting pancreatitis (see section
4).
- type 1 diabetes
- diabetic ketoacidosis (a complication of diabetes with high blood sugar, rapid weight
loss, nausea or vomiting)
- any past or present kidney problems
- an allergic reaction to Sitajub (see section 4).
This medicine is unlikely to cause low blood sugar because it does not work when your blood
sugar is low. However, when this medicine is used in combination with a sulphonylurea
medicine or with insulin, low blood sugar (hypoglycaemia) can occur. Your doctor may
reduce the dose of your sulphonylurea or insulin medicine.
Children and adolescents
Children and adolescents below 18 years should not use this medicine. It is not effective in
children and adolescents between the ages of 10 and 17 years. It is not known if this medicine
is safe and effective when used in children younger than 10 years.
Other medicines and Sitajub
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines.
In particular, tell your doctor if you are taking digoxin (a medicine used to treat irregular
heartbeat and other heart problems). The level of digoxin in your blood may need to be
checked if taking with Sitajub.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a
baby, ask your doctor or pharmacist for advice before taking this medicine.
You should not take this medicine during pregnancy.
It is not known if this medicine passes into breast milk. You should not take this medicine if
you are breastfeeding or plan to breastfeed.
Driving and using machines
This medicine has no or negligible influence on the ability to drive and use machines.
However, dizziness and drowsiness have been reported, which may affect your ability to drive
or use machines.
Taking this medicine in combination with medicines called sulphonylureas or with insulin can
cause hypoglycaemia, which may affect your ability to drive and use machines or work
without safe foothold.

Always take this medicine exactly as your doctor has told you. Check with your doctor or
pharmacist if you are not sure.
The usual recommended dose is:
- one 100 mg film-coated tablet
- once a day
- by mouth
If you have kidney problems, your doctor may prescribe lower doses (such as 25 mg or 50
mg).
You can take this medicine with or without food and drink.
Your doctor may prescribe this medicine alone or with certain other medicines that lower
blood sugar.
Diet and exercise can help your body use its blood sugar better. It is important to stay on the
diet and exercise recommended by your doctor while taking Sitajub.
If you take more Sitajub than you should
If you take more than the prescribed dosage of this medicine, contact your doctor
immediately.
If you forget to take Sitajub
If you miss a dose, take it as soon as you remember. If you do not remember until it is time
for your next dose, skip the missed dose and go back to your regular schedule. Do not take a
double dose of this medicine.
If you stop taking Sitajub
Continue to take this medicine as long as your doctor prescribes it so you can continue to help
control your blood sugar. You should not stop taking this medicine without talking to your
doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking Sitajub and contact a doctor immediately if you notice any of the following
serious side effects:
- Severe and persistent pain in the abdomen (stomach area) which might reach through to
Your back with or without nausea and vomiting, as these could be signs of an inflamed
pancreas (pancreatitis).
If you have a serious allergic reaction (frequency not known), including rash, hives, blisters
on the skin/peeling skin and swelling of the face, lips, tongue, and throat that may cause
difficulty in breathing or swallowing, stop taking this medicine and call your doctor right
away. Your doctor may prescribe a medicine to treat your allergic reaction and a different
medicine for your diabetes.
Some patients have experienced the following side effects after adding sitagliptin to
metformin:
Common (may affect up to 1 in 10 people): low blood sugar, nausea, flatulence, vomiting
Uncommon (may affect up to 1 in 100 people): stomach ache, diarrhoea, constipation,
drowsiness
Some patients have experienced different types of stomach discomfort when starting the
combination of sitagliptin and metformin together (frequency is common).
Some patients have experienced the following side effects while taking sitagliptin in
combination with a sulphonylurea and metformin:
Very common (may affect more than 1 in 10 people): low blood sugar
Common: constipation
Some patients have experienced the following side effects while taking sitagliptin and pioglitazone:
Common: flatulence, swelling of the hands or legs
Some patients have experienced the following side effects while taking sitagliptin in combination
with pioglitazone and metformin:
Common: swelling of the hands or legs
Some patients have experienced the following side effects while taking sitagliptin in combination
with insulin (with or without metformin):
Common: flu
Uncommon: dry mouth
Some patients have experienced the following side effects while taking sitagliptin alone in clinical
studies, or during post-approval use alone and/or with other diabetes medicines:
Common: low blood sugar, headache, upper respiratory infection, stuffy or runny nose and sore
throat,
osteoarthritis, arm or leg pain
Uncommon: dizziness, constipation, itching
Rare: reduced number of platelets
Frequency not known: kidney problems (sometimes requiring dialysis), vomiting, joint pain,
muscle pain, back pain, interstitial lung disease, bullous pemphigoid (a type of skin blister)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet.

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after
‘EXP’. The expiry date refers to the last day of that month.
Store below 30℃.
Do not throw away medicines via wastewater or household waste. Ask your pharmacist how
to throw away medicines you no longer use. These measures will help protect the
environment.